Edit |   |
---|---|
Antigenic Specificity | EGFR, Human (Zalutumumab biosimilar) |
Clone | Zalutumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human EGFR Recombinant Antibody (Zalutumumab). Zalutumumab (proposed trade name HuMax-EGFR) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFR). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. |
Immunogen | n/a |
Other Names | Anti-EGFR Recombinant Antibody, Research Grade Zalutumumab, Anti-Human EGFR Recombinant Antibody(Zalutumumab), HuMax-EGFr, Antibody Drug Analogues, Monoclonal Antibody, YR1134, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 667901-13-5 |
Catalog # | YR1134 |
Price | please inquire |
Order / More Info | EGFR, Human (Zalutumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |